行情

ARMP

ARMP

Armata医药
AMEX

实时行情|Nasdaq Last Sale

4.170
-0.350
-7.74%
休市 16:00 05/27 EDT
开盘
4.489
昨收
4.520
最高
4.520
最低
4.170
成交量
1,928
成交额
5,193
52周最高
6.49
52周最低
2.820
市值
1.51亿
市盈率(TTM)
-4.1671
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解ARMP最新的财务预测,通过ARMP每股收益,每股净资产,每股现金流等数据分析Armata医药近期的经营情况,然后做出明智的投资选择。
分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

33.33%强力推荐
66.67%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测ARMP价格均价为7.67,最高价位9.00,最低价为7.00。
最高9.00
均价7.67
最低7.00
现价4.170
EPS
实际EPS
预期EPS
-0.24-0.18-0.12-0.06
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
机构持股
总机构数: 13
机构持股: 11.95万
持股比例: 0.33%
总股本: 3,611.23万
类型机构数股数
增持
4
4.38万
建仓
0
0
减持
5
14.72万
平仓
13
3.60万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+3.72%
制药与医学研究
+1.28%
高管信息
Chief Executive Officer/Director
Brian Varnum
Chief Financial Officer
Steven Martin
Vice President - Finance/Vice President - Administration
Erin Butler
Vice President - Operations
Duane Morris
Vice President
Mina Pastagia
Director
Todd Patrick
Independent Director
Jules Haimovitz
Independent Director
Odysseas Kostas
Independent Director
Robin Kramer
Independent Director
Joseph Patti
Independent Director
Todd Peterson
Independent Director
Sarah Schlesinger
暂无数据
暂无数据
ARMP 简况
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using bacteriophage-based technology. The Company is a developer of synthetic phage platform, which targets therapeutics for the treatment of various multidrug-resistant bacterial infections. It develops synthetic phage products that target a specific pathogen begins with the isolation of natural phages from environmental and clinical samples. Each product candidate combines several chosen phages, which target a specific disease-causing bacterial pathogen, such as staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa) and clostridium difficile (C. difficile). Its product candidates are AP-PA02 and AP-SA02.

微牛提供Armata Pharmaceuticals Inc(AMEX-ARMP)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ARMP股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ARMP股票基本功能。